Registered number: 08553103 | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
FOR THE YEAR ENDED 30/06/2020 | ||||||||
|
||||||||
Prepared By: | ||||||||
David Reed Associates Ltd | ||||||||
54D Frome Road | ||||||||
Bradford on Avon | ||||||||
Wiltshire | ||||||||
BA15 1LA |
|
||||||||
Glentham Life Sciences Limited | ||||||||
|
ACCOUNTS | ||||||||
FOR THE YEAR ENDED 30/06/2020 | ||||||||
DIRECTORS | ||||||||
|
||||||||
|
||||||||
REGISTERED OFFICE | ||||||||
|
||||||||
|
||||||||
|
||||||||
Wiltshire | ||||||||
|
||||||||
COMPANY DETAILS | ||||||||
Private company limited by shares registered in EW - England and Wales, registered number 08553103 | ||||||||
ACCOUNTANTS | ||||||||
David Reed Associates Ltd | ||||||||
54D Frome Road | ||||||||
Bradford on Avon | ||||||||
Wiltshire | ||||||||
BA15 1LA |
|
||||||||
Glentham Life Sciences Limited | ||||||||
|
ACCOUNTS | ||||||||
FOR THE YEAR ENDED 30/06/2020 | ||||||||
CONTENTS | ||||||||
Page | ||||||||
Directors' Report | - | |||||||
Accountants' Report | - | |||||||
Statement Of Comprehensive Income | - | |||||||
Balance Sheet | 3 | |||||||
Notes To The Accounts | 4 | |||||||
The following do not form part of the statutory financial statements: | ||||||||
Trading And Profit And Loss Account | - | |||||||
Profit And Loss Account Summaries | - |
|
||||||||
Glentham Life Sciences Limited | ||||||||
|
BALANCE SHEET AT
|
||||||||||
2020 | 2019 | |||||||||
Notes | £ | £ | ||||||||
FIXED ASSETS | ||||||||||
Tangible assets | 2 |
|
|
|||||||
CURRENT ASSETS | ||||||||||
Stock |
|
|
||||||||
Debtors | 4 |
|
|
|||||||
Cash at bank and in hand |
|
|
||||||||
1,695,869 | 1,681,437 | |||||||||
CREDITORS: Amounts falling due within one year | 5 |
|
|
|||||||
NET CURRENT ASSETS |
|
1,281,192 | ||||||||
TOTAL ASSETS LESS CURRENT LIABILITIES |
|
|
||||||||
PROVISIONS FOR LIABILITIES AND CHARGES | 7 |
|
|
|||||||
NET ASSETS |
|
|
||||||||
CAPITAL AND RESERVES | ||||||||||
Called up share capital | 8 |
|
|
|||||||
Profit and loss account | 1,581,058 | 1,637,492 | ||||||||
SHAREHOLDERS' FUNDS |
|
|
||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
Approved by the board on
|
||||||||||
............................. | ||||||||||
|
||||||||||
Director | ||||||||||
|
||||||||
Glentham Life Sciences Limited | ||||||||
|
NOTES TO THE ACCOUNTS | ||||||||||
FOR THE YEAR ENDED 30/06/2020 | ||||||||||
1. ACCOUNTING POLICIES |
1a. Basis Of Accounting | ||||||||
The accounts have been prepared under the historical cost convention. | ||||||||
The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 . |
1b. Depreciation | ||||||||
|
||||||||
Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the costs, less estimated residual value or each asset, evenly over its expected useful life, as follows: | ||||||||
Land And Buildings | straight line 2 % | |||||||
Plant And Machinery | reducing balance 25 % |
1c. Stocks | ||||||||
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs. | ||||||||
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs. |
1d. Pension Costs | ||||||||
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year. |
1e. Foreign Currency | ||||||||
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charges to the profit or loss. |
|
||||||||
Glentham Life Sciences Limited | ||||||||
|
1f. Turnover | ||||||||
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
1g. Debtors | ||||||||
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
1h. Creditors | ||||||||
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest methods. |
2. TANGIBLE FIXED ASSETS | ||||||
Land And | Plant and | |||||
Buildings | Machinery | Total | ||||
£ | £ | £ | ||||
Cost | ||||||
At 01/07/2019 | 339,807 | 82,254 | 422,061 | |||
Additions | 1,650 | 15,714 | 17,364 | |||
At 30/06/2020 | 341,457 | 97,968 | 439,425 | |||
Depreciation | ||||||
At 01/07/2019 | 15,735 | 42,672 | 58,407 | |||
For the year | 4,829 | 13,824 | 18,653 | |||
At 30/06/2020 | 20,564 | 56,496 | 77,060 | |||
Net Book Amounts | ||||||
At 30/06/2020 |
|
|
362,365 | |||
At 30/06/2019 |
|
|
363,654 | |||
3. STOCK | 2020 | 2019 | ||||
£ | £ | |||||
Stock comprises: | ||||||
Stock |
|
|
||||
|
|
|
||||||||
Glentham Life Sciences Limited | ||||||||
|
4. DEBTORS | 2020 | 2019 | ||||||
£ | £ | |||||||
Amounts falling due within one year | ||||||||
Trade debtors | 376,972 | 405,127 | ||||||
Other debtors | 51,390 | 26,290 | ||||||
Amounts due from group companies | 1,870 | - | ||||||
Prepayments | 1,245 | 833 | ||||||
431,477 | 432,250 | |||||||
5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
2020 | 2019 | |||||||
£ | £ | |||||||
Other taxes and social security costs | 184,728 | 190,486 | ||||||
PAYE control | 2,916 | - | ||||||
Other creditors | 9,764 | 11,732 | ||||||
Trade creditors | 268,353 | 191,968 | ||||||
Other creditors | 678 | - | ||||||
Accruals | 2,757 | 6,059 | ||||||
469,196 | 400,245 | |||||||
6. EMPLOYEES | ||||||
2020 | 2019 | |||||
No. | No. | |||||
Average number of employees |
|
7 | ||||
7. PROVISIONS FOR LIABILITIES | 2020 | 2019 | ||||||
£ | £ | |||||||
Other provisions | 7,880 | 7,254 | ||||||
7,880 | 7,254 | |||||||
|
||||||||
Glentham Life Sciences Limited | ||||||||
|
8. SHARE CAPITAL | 2020 | 2019 | ||||||
£ | £ | |||||||
Allotted, issued and fully paid: | ||||||||
|
100 | 100 | ||||||
100 | 100 | |||||||